SonoRobotics is an ETH Zurich spin-off developing innovative catheters for rapid thrombus disruption and microvascular protection in PCI.
Team
Team
Team
Daniel Ahmed
Founder, CEO
Daniel Ahmed leads the company’s scientific and strategic development. With over 20 years of experience in ultrasound technologies, he has driven advances in ultrasound-based manipulation, robotics, and microtechnologies, with work published in Nature, Science Robotics, Nature Electronics, Nature Machine Intelligence, and other leading journals. He has secured funding through competitive European and Swiss programs, including ERC, SNSF, BRIDGE, and EIC awards. Daniel is the recipient of the Falling Walls Science Breakthrough of the Year 2021 in Engineering & Technology, the ETH Zurich Dandelion Entrepreneurship Award, and a DWI Fellowship at Aachen University. He is Associate Professor at the ARTORG Center, University of Bern, and was previously Assistant Professor of Acoustic Robotics at ETH Zurich.
Daniel Ahmed leads the company’s scientific and strategic development. With over 20 years of experience in ultrasound technologies, he has driven advances in ultrasound-based manipulation, robotics, and microtechnologies, with work published in Nature, Science Robotics, Nature Electronics, Nature Machine Intelligence, and other leading journals. He has secured funding through competitive European and Swiss programs, including ERC, SNSF, BRIDGE, and EIC awards. Daniel is the recipient of the Falling Walls Science Breakthrough of the Year 2021 in Engineering & Technology, the ETH Zurich Dandelion Entrepreneurship Award, and a DWI Fellowship at Aachen University. He is Associate Professor at the ARTORG Center, University of Bern, and was previously Assistant Professor of Acoustic Robotics at ETH Zurich.
Anil Sethi
Co-founder, CBO
Anil Sethi, Chief Business Officer, leads business development and commercialization. A serial entrepreneur and Entrepreneur-in-Residence at ETH Zurich, he has founded and scaled multiple startups, including ETH spin-off Flisom, where he served as CEO and CFO and helped raise over CHF 100 million before a successful exit. He has taught entrepreneurship at ETH Zurich for many years, mentored numerous founders, and is the author of From Science to Startup and From Startup to Unicorn. He strengthens the company’s commercial strategy, business development, and financing capabilities.
Anil Sethi, Chief Business Officer, leads business development and commercialization. A serial entrepreneur and Entrepreneur-in-Residence at ETH Zurich, he has founded and scaled multiple startups, including ETH spin-off Flisom, where he served as CEO and CFO and helped raise over CHF 100 million before a successful exit. He has taught entrepreneurship at ETH Zurich for many years, mentored numerous founders, and is the author of From Science to Startup and From Startup to Unicorn. He strengthens the company’s commercial strategy, business development, and financing capabilities.
Advisory Board
Advisory Board
Advisory Board
Dr. Jurjen Zoethout
Regulatory Advisor
Dr. Jurjen Zoethout advises the company on FDA and EU regulatory strategy. With over 25 years of experience in MedTech, he is an expert in regulatory, quality, and clinical affairs, with a strong track record of guiding companies through complex US and European approval pathways, enabling compliant product launches, and managing interactions with regulatory authorities. He has coached numerous startups, co-founded three innovation-driven companies, and supported the growth of multiple MedTech ventures.
Dr. Jurjen Zoethout advises the company on FDA and EU regulatory strategy. With over 25 years of experience in MedTech, he is an expert in regulatory, quality, and clinical affairs, with a strong track record of guiding companies through complex US and European approval pathways, enabling compliant product launches, and managing interactions with regulatory authorities. He has coached numerous startups, co-founded three innovation-driven companies, and supported the growth of multiple MedTech ventures.
Prof. Dr. med. Lorenz Räber
Clinical Advisor